Hospital del Mar Parc de Salut Mar

Barcelona 08003

1 studies enrolling now · 11 studies all time

What they study most

Advanced Non Small Cell Lung Cancer, Chronic Heart Failure, Diffuse Large B-cell Lymphoma, HNSCC, HRAS Gene Mutation, Kidney Transplant Rejection, Liver Stiffness, Metastatic Castration-resistant Prostate Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Prostate Cancer, NASH - Nonalcoholic Steatohepatitis, Primary Biliary Cholangitis

Studies at this site

• Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation — Completed
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction — Completed
• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer — Stopped early
• Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients — Enrolling by invitation
• A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness — Completed
• A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL) — Stopped early
• Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation — Running, not enrolling
• Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy — Completed
• Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis — Completed